Adial Pharmaceuticals (ADIL) Short Interest Ratio & Short Volume $0.38 +0.01 (+2.15%) Closing price 04:00 PM EasternExtended Trading$0.37 -0.01 (-2.39%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adial Pharmaceuticals Short Interest DataAdial Pharmaceuticals (ADIL) has a short interest of 3.48 million shares, representing 16.82% of the float (the number of shares available for trading by the public). This marks a 919.93% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 4.09 million shares to cover all short positions.Current Short Interest3,480,000 sharesPrevious Short Interest341,200 sharesChange Vs. Previous Month+919.93%Dollar Volume Sold Short$1.52 millionShort Interest Ratio0.4 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares21,830,000 sharesShort Percent of Float16.82%Today's Trading Volume685,614 sharesAverage Trading Volume4,093,891 sharesToday's Volume Vs. Average17% Short Selling Adial Pharmaceuticals? Sign up to receive the latest short interest report for Adial Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADIL Short Interest Over TimeADIL Days to Cover Over TimeADIL Percentage of Float Shorted Over Time Adial Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20253,480,000 shares $1.52 million +919.9%16.8%0.4 $0.44 7/15/2025341,200 shares $125.56 thousand -63.5%2.3%0 $0.37 6/30/2025933,700 shares $282.16 thousand +90.5%6.5%0.1 $0.30 6/15/2025490,100 shares $171.58 thousand +264.9%3.4%0.2 $0.35 5/31/2025134,300 shares $88.65 thousand -63.0%1.7%0.2 $0.66 5/15/2025362,900 shares $239.51 thousand +159.6%4.7%0.3 $0.66 4/30/2025139,800 shares $96.46 thousand -35.6%2.2%0.1 $0.69 4/15/2025217,100 shares $154.58 thousand -48.0%3.4%0.3 $0.71 3/31/2025417,400 shares $264.72 thousand -24.0%6.5%0.5 $0.63 3/15/2025549,400 shares $381.23 thousand -19.8%8.5%0.7 $0.69 Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025685,300 shares $537.96 thousand +610.2%10.6%0.8 $0.79 2/15/202596,500 shares $71.53 thousand +59.2%1.5%0.1 $0.74 1/31/202560,600 shares $50.30 thousand +195.6%1.0%0.3 $0.83 1/15/202520,500 shares $20.91 thousand -9.3%0.3%0.1 $1.02 12/31/202422,600 shares $22.83 thousand -60.8%0.4%0.1 $1.01 12/15/202457,600 shares $62.78 thousand +16.4%0.9%0.3 $1.09 11/30/202449,500 shares $49.50 thousand -71.7%0.8%0.3 $1.00 11/15/2024175,000 shares $185.50 thousand +121.8%2.8%1.2 $1.06 10/31/202478,900 shares $78.90 thousand +54.1%1.3%0.6 $1.00 10/15/202451,200 shares $48.76 thousand -34.2%0.8%0.2 $0.95 9/30/202477,800 shares $77.72 thousand -47.0%1.2%0 $1.00 9/15/2024146,700 shares $158.44 thousand -46.2%2.3%0.1 $1.08 8/31/2024272,800 shares $267.62 thousand -14.5%4.3%0.1 $0.98 8/15/2024318,900 shares $309.05 thousand +8.3%5.1%0.1 $0.97 7/31/2024294,400 shares $306.18 thousand +92.5%7.2%0.1 $1.04 7/15/2024152,900 shares $169.72 thousand -6.4%3.7%0.1 $1.11 6/30/2024163,300 shares $187.80 thousand -25.2%4.0%0.1 $1.15 6/15/2024218,200 shares $285.84 thousand +33.5%5.3%0.1 $1.31 5/31/2024163,400 shares $236.93 thousand +23.5%4.0%0.1 $1.45 5/15/2024132,300 shares $187.87 thousand -20.8%3.2%0 $1.42 4/30/2024167,100 shares $284.07 thousand -83.5%4.4%0 $1.70 4/15/20241,010,000 shares $2.64 million +11,509.2%26.7%0.2 $2.61 3/31/20248,700 shares $11.57 thousand -91.8%0.2%0 $1.33 3/15/2024105,600 shares $166.85 thousand +275.8%7.0%0 $1.58 2/29/202428,100 shares $57.32 thousand -83.8%1.9%0 $2.04 2/15/2024173,300 shares $201.03 thousand +691.3%11.5%0.6 $1.16 1/31/202421,900 shares $24.97 thousand -41.1%1.5%0.2 $1.14 1/15/202437,200 shares $53.98 thousand +11.4%2.6%0.4 $1.45 12/31/202333,400 shares $62.12 thousand +29.5%3.2%0.3 $1.86 12/15/202325,800 shares $45.15 thousand -37.4%2.4%0.3 $1.75The stealth altcoin the financial world is underestimating (Ad)This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.Discover the protocol that's quietly replacing traditional finance. 11/30/202341,200 shares $90.23 thousand -22.3%3.9%0.6 $2.19 11/15/202353,000 shares $112.36 thousand -1.5%5.0%1.2 $2.12 10/31/202353,800 shares $103.83 thousand +93.5%5.1%0.8 $1.93 10/15/202327,800 shares $77.01 thousand -45.3%2.6%0.4 $2.77 9/30/202350,800 shares $141.22 thousand +49.4%4.8%0.3 $2.78 9/15/202334,000 shares $99.62 thousand -47.4%3.3%0.3 $2.93 8/31/202364,600 shares $282.95 thousand -12.6%6.2%0.5 $4.38 8/15/202373,900 shares $283.92 thousand +121.3%7.1%0.6 $3.84 7/31/202333,400 shares $268.04 thousand -97.7%N/A0.3 $8.03 7/15/20231,430,000 shares $395.54 thousand +3,084.9%N/A0.6 $0.28 6/30/202344,900 shares $9.35 thousand -24.3%N/A0 $0.21 6/15/202359,300 shares $14.53 thousand -36.4%N/A0.3 $0.25 5/31/202393,200 shares $24.51 thousand -71.3%N/A0.3 $0.26 5/15/2023324,800 shares $104.81 thousand -22.0%N/A0.5 $0.32 4/30/2023416,400 shares $143.45 thousand +42.6%N/A0.6 $0.34 4/15/2023292,100 shares $87.05 thousand -12.0%N/A0.4 $0.30 3/31/2023332,000 shares $116.20 thousand -38.8%N/A0.5 $0.35 3/15/2023542,700 shares $201.88 thousand +42.2%N/A0.8 $0.37 2/28/2023381,600 shares $167.90 thousand +37.9%N/A0.6 $0.44 2/15/2023276,700 shares $102.66 thousand +105.9%N/A1.1 $0.37 1/31/2023134,400 shares $63.17 thousand -7.0%N/A0.6 $0.47 1/15/2023144,500 shares $46.25 thousand +12.3%N/A1 $0.32 12/30/2022128,700 shares $27.67 thousand -4.0%N/A1 $0.22 12/15/2022134,100 shares $32.57 thousand +4.0%N/A1.4 $0.24 11/30/2022128,900 shares $34.79 thousand -3.9%N/A1.3 $0.27 11/15/2022134,100 shares $39.44 thousand -9.4%N/A0.9 $0.29 10/31/2022148,000 shares $43.66 thousand -8.0%N/A0.9 $0.30 10/15/2022160,900 shares $52.61 thousand -8.0%N/A0.6 $0.33 9/30/2022174,900 shares $61.22 thousand -28.9%N/A0.3 $0.35 9/15/2022246,000 shares $119.78 thousand -26.8%N/A0.3 $0.49 8/31/2022335,900 shares $180.31 thousand +10.1%N/A0.4 $0.54 8/15/2022305,200 shares $181.59 thousand -52.4%N/A0.4 $0.60 7/31/2022641,700 shares $417.11 thousand -6.4%N/A0.9 $0.65 7/15/2022685,300 shares $1.12 million +17.9%N/A1.1 $1.63 6/30/2022581,500 shares $779.21 thousand -27.4%N/A2.6 $1.34 6/15/2022801,200 shares $1.00 million -3.0%N/A4.7 $1.25 5/31/2022825,800 shares $1.04 million -4.8%N/A6.2 $1.26 5/15/2022867,100 shares $1.11 million +0.8%N/A7.6 $1.28 4/30/2022860,300 shares $1.21 million -8.3%N/A7.4 $1.41 4/15/2022938,000 shares $1.64 million +10.5%N/A7.8 $1.75 3/31/2022849,100 shares $1.71 million -2.1%N/A7.3 $2.01 3/15/2022867,000 shares $1.59 million +5.9%N/A7.4 $1.83 2/28/2022818,500 shares $1.69 million +8.3%N/A6.7 $2.06 2/15/2022755,600 shares $1.65 million +2.2%N/A5.1 $2.18 1/31/2022739,700 shares $1.54 million -9.0%4.3%4.3 $2.08 1/15/2022812,600 shares $2.13 million -5.7%4.7%4.1 $2.62 12/31/2021861,500 shares $2.33 million +1.1%5.0%3.8 $2.70 12/15/2021852,100 shares $2.29 million -9.5%4.9%3.1 $2.69 11/30/2021941,200 shares $2.62 million -5.5%5.6%3 $2.78 11/15/2021995,700 shares $3.15 million +13.7%5.9%2.6 $3.16The stealth altcoin the financial world is underestimating (Ad)This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.Discover the protocol that's quietly replacing traditional finance. 10/29/2021875,600 shares $2.81 million -11.0%5.3%1.9 $3.21 10/15/2021984,100 shares $3.82 million +3.4%6.0%2.1 $3.88 9/30/2021951,400 shares $4.08 million +10.3%5.8%1.6 $4.29 9/15/2021862,500 shares $3.54 million -3.0%5.3%1 $4.10 8/31/2021888,900 shares $3.64 million -10.0%5.6%0.7 $4.10 8/13/2021987,800 shares $3.24 million -9.4%6.0%0.8 $3.28 7/30/20211,090,000 shares $2.66 million +16.9%6.2%0.9 $2.44 7/15/2021932,600 shares $2.32 million -24.8%5.8%0.8 $2.49 6/30/20211,240,000 shares $3.16 million +103.0%7.9%1.2 $2.55 6/15/2021611,000 shares $1.65 million -13.4%3.9%0.8 $2.70 5/28/2021705,700 shares $1.74 million +11.4%4.6%2.9 $2.47 5/14/2021633,500 shares $1.30 million -4.2%N/A1.8 $2.05 4/30/2021661,100 shares $1.44 million -9.7%N/A1.4 $2.17 4/15/2021731,900 shares $1.69 million +16.5%N/A1.2 $2.31 3/31/2021628,000 shares $1.44 million +14.8%N/A0.9 $2.30 3/15/2021547,200 shares $1.41 million +8.2%N/A0.8 $2.57 2/26/2021505,700 shares $1.39 million +7.6%N/A0.8 $2.75 2/12/2021469,800 shares $1.37 million +35.8%N/A0.7 $2.91 1/29/2021346,000 shares $743.90 thousand -6.4%N/A0.6 $2.15 1/15/2021369,800 shares $761.79 thousand +16.2%N/A0.7 $2.06 12/31/2020318,300 shares $569.76 thousand -5.7%N/A0.5 $1.79 12/15/2020337,400 shares $651.18 thousand -7.2%N/A0.1 $1.93 11/30/2020363,700 shares $709.22 thousand -14.5%N/A0.1 $1.95 11/15/2020425,600 shares $783.10 thousand -32.8%N/A0.2 $1.84 10/30/2020633,000 shares $1.13 million +13.2%N/A0.3 $1.79 10/15/2020559,200 shares $1.08 million -9.2%N/A0.2 $1.94 9/30/2020615,500 shares $1.37 million +9.7%N/A0.2 $2.23 9/15/2020561,000 shares $746.13 thousand +9.0%N/A0.7 $1.33 8/31/2020514,800 shares $710.42 thousand +97.6%N/A0.5 $1.38 ADIL Short Interest - Frequently Asked Questions What is Adial Pharmaceuticals' current short interest? Short interest is the volume of Adial Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 3,480,000 shares of ADIL short. 16.82% of Adial Pharmaceuticals' shares are currently sold short. Learn More on Adial Pharmaceuticals' current short interest. What is a good short interest percentage for Adial Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.82% of Adial Pharmaceuticals' floating shares are currently sold short. Is Adial Pharmaceuticals' short interest increasing or decreasing? Adial Pharmaceuticals saw a increase in short interest in July. As of July 31st, there was short interest totaling 3,480,000 shares, an increase of 919.9% from the previous total of 341,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adial Pharmaceuticals' short interest compare to its competitors? 16.82% of Adial Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adial Pharmaceuticals: Equillium, Inc. (2.43%), Rani Therapeutics Holdings, Inc. (3.12%), SCYNEXIS, Inc. (1.40%), Mersana Therapeutics, Inc. (8.01%), Akari Therapeutics PLC (0.15%), Estrella Immunopharma, Inc. (1.61%), Clene Inc. (3.90%), Mural Oncology PLC (2.01%), Kezar Life Sciences, Inc. (9.46%), MIRA Pharmaceuticals, Inc. (3.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Adial Pharmaceuticals stock? Short selling ADIL is an investing strategy that aims to generate trading profit from Adial Pharmaceuticals as its price is falling. ADIL shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adial Pharmaceuticals? A short squeeze for Adial Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADIL, which in turn drives the price of the stock up even further. How often is Adial Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADIL, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies EQ Short Interest Data RANI Short Interest Data SCYX Short Interest Data MRSN Short Interest Data AKTX Short Interest Data ESLA Short Interest Data CLNN Short Interest Data MURA Short Interest Data KZR Short Interest Data MIRA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADIL) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access